A detailed history of Castleview Partners, LLC transactions in Bruker Corp stock. As of the latest transaction made, Castleview Partners, LLC holds 191 shares of BRKR stock, worth $10,864. This represents 0.01% of its overall portfolio holdings.

Number of Shares
191
Previous 134 42.54%
Holding current value
$10,864
Previous $9,000 44.44%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$60.3 - $70.67 $3,437 - $4,028
57 Added 42.54%
191 $13,000
Q2 2024

Jul 31, 2024

BUY
$63.57 - $92.93 $4,449 - $6,505
70 Added 109.38%
134 $8,000
Q1 2024

May 09, 2024

BUY
$69.21 - $94.27 $968 - $1,319
14 Added 28.0%
64 $6,000
Q4 2023

Feb 05, 2024

BUY
$54.91 - $74.64 $2,745 - $3,732
50 New
50 $3,000

Others Institutions Holding BRKR

About BRUKER CORP


  • Ticker BRKR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 148,138,000
  • Market Cap $8.43B
  • Description
  • Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, ...
More about BRKR
Track This Portfolio

Track Castleview Partners, LLC Portfolio

Follow Castleview Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleview Partners, LLC with notifications on news.